Zapping kidney nerves: a Needle-Free hope for high blood pressure?
NCT ID NCT07664787
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tests a new device that uses radiofrequency energy to calm overactive kidney nerves, which can drive high blood pressure. Twenty adults with untreated mild hypertension will either get the real procedure or a sham (fake) one. The main goal is to see if the real treatment safely lowers 24-hour blood pressure more than the sham at 3 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Six-channel radiofrequency ablation system (device) for renal denervation
What this could lead to
If successful, this could offer a drug-free alternative to control early-stage high blood pressure, potentially reducing long-term medication needs.
What could go wrong
This is a very small pilot study (20 people) with no phase, so results are preliminary. The procedure involves risks like bleeding or vessel damage, and it may not lower blood pressure enough to be worthwhile.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••